{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:25:30Z","timestamp":1787793930969,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13555-024-01132-0","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T03:02:01Z","timestamp":1709866921000},"page":"1497-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-0290","authenticated-orcid":false,"given":"Anthony","family":"Bewley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hiribarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-2129","authenticated-orcid":false,"given":"Jordi","family":"Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1296-4520","authenticated-orcid":false,"given":"Sicily","family":"Mburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"key":"1132_CR2","unstructured":"National Psoriasis Foundation. Psoriasis statistics. 2022. https:\/\/www.psoriasis.org\/psoriasis-statistics\/. Accessed 20 Oct 2023."},{"issue":"5","key":"1132_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1132_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3):170\u20133.","journal-title":"Clin Med (Lond)"},{"issue":"Suppl 3","key":"1132_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1468-3083.2012.04525.x","volume":"26","author":"S Devaux","year":"2012","unstructured":"Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):61\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1132_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/2229-5178.209622","volume":"8","author":"R Torsekar","year":"2017","unstructured":"Torsekar R, Gautam MM. Topical therapies in psoriasis. Indian Dermatol Online J. 2017;8(4):235\u201345.","journal-title":"Indian Dermatol Online J"},{"issue":"6","key":"1132_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaad.2007.06.042","volume":"57","author":"EJ Horn","year":"2007","unstructured":"Horn EJ, Fox KM, Patel V, Chiou C-F, Dann F, Lebwohl M. Are patients with psoriasis undertreated? results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57(6):957\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1132_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000313825","volume":"221","author":"C Blome","year":"2010","unstructured":"Blome C, Simianer S, Purwins S, et al. Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology. 2010;221(2):154\u20139.","journal-title":"Dermatology"},{"issue":"10","key":"1132_CR9","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1517\/17425247.2012.711756","volume":"9","author":"X Tan","year":"2012","unstructured":"Tan X, Feldman SR, Chang J, Balkrishnan R. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263\u201371.","journal-title":"Expert Opin Drug Deliv"},{"issue":"Suppl 4","key":"1132_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-3083.2011.04060.x","volume":"25","author":"A Bewley","year":"2011","unstructured":"Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/PPA.S117006","volume":"10","author":"I Belinch\u00f3n","year":"2016","unstructured":"Belinch\u00f3n I, Rivera R, Blanch C, Comellas M, Liz\u00e1n L. Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence. 2016;10:2357\u201367.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"1132_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","volume":"59","author":"A Storm","year":"2008","unstructured":"Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59(1):27\u201333.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1132_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jaad.2008.07.039","volume":"59","author":"A Storm","year":"2008","unstructured":"Storm A, Benfeldt E, Andersen SE, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59(6):975\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 3","key":"1132_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1468-3083.2005.01329.x","volume":"19","author":"S Fou\u00e9r\u00e9","year":"2005","unstructured":"Fou\u00e9r\u00e9 S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005;19(Suppl 3):2\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1132_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2005.12.021","volume":"55","author":"KK Brown","year":"2006","unstructured":"Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607\u201313.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1132_CR16","first-page":"581","volume":"41","author":"HL Richards","year":"1999","unstructured":"Richards HL, Fortune DG, O\u2019Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1132_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/archderm.140.4.408","volume":"140","author":"SS Zaghloul","year":"2004","unstructured":"Zaghloul SS, Goodfield MJD. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140(4):408\u201314.","journal-title":"Arch Dermatol"},{"issue":"10","key":"1132_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/pharmaceutics13101539","volume":"13","author":"A Teixeira","year":"2021","unstructured":"Teixeira A, Teixeira M, Almeida V, et al. Does the vehicle matter? real-world evidence on adherence to topical treatment in psoriasis. Pharmaceutics. 2021;13(10):1539.","journal-title":"Pharmaceutics."},{"issue":"3","key":"1132_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/bjd.15085","volume":"176","author":"H Alinia","year":"2017","unstructured":"Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176(3):759\u201364.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1132_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1365-2133.2004.06174.x","volume":"151","author":"CL Carroll","year":"2004","unstructured":"Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004;151(4):895\u20137.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1132_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ad.2012.12.005","volume":"104","author":"L Puig","year":"2013","unstructured":"Puig L, Carrascosa JM, Belinch\u00f3n I, et al. Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr. 2013;104(6):488\u201396.","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"1132_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00403-018-1808-x","volume":"310","author":"AG Florek","year":"2018","unstructured":"Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310(4):271\u2013319.","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"1132_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/09546634.2018.1544410","volume":"30","author":"V Vasconcelos","year":"2019","unstructured":"Vasconcelos V, Teixeira A, Almeida V, et al. Patient preferences for attributes of topical anti-psoriatic medicines. J Dermatolog Treat. 2019;30(7):659\u201363.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"1132_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s13555-020-00368-w","volume":"10","author":"B Kowalewska","year":"2020","unstructured":"Kowalewska B, Cybulski M, Jankowiak B, Krajewska-Ku\u0142ak E. Acceptance of Illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: a cross-sectional study. Dermatol Ther (Heidelb). 2020;10(3):413\u201330.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1132_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13555-020-00363-1","volume":"10","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, Kowalewska B, Krajewska-Ku\u0142ak E, Khvorik DF. Stigmatization and quality of life in patients with psoriasis. Dermatol Ther (Heidelb). 2020;10(2):285\u201396.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"1132_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.12740\/PP\/68848","volume":"51","author":"T Zi\u0119ciak","year":"2017","unstructured":"Zi\u0119ciak T, Rzepa T, Kr\u00f3l J, \u017baba R. Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr Pol. 2017;51(6):1153\u201363.","journal-title":"Psychiatr Pol"},{"issue":"1","key":"1132_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamadermatol.2015.3605","volume":"152","author":"BE Cohen","year":"2016","unstructured":"Cohen BE, Martires KJ, Ho RS. Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009\u20132012. JAMA Dermatol. 2016;152(1):73\u20139.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"1132_CR28","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2014.530","volume":"135","author":"FJ Dalgard","year":"2015","unstructured":"Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984\u201391.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1132_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/09546634.2017.1395800","volume":"29","author":"JJ Wu","year":"2018","unstructured":"Wu JJ, Feldman SR, Koo J, Marangell LB. Epidemiology of mental health comorbidity in psoriasis. J Dermatol Treat. 2018;29(5):487\u201395.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"1132_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/bjd.14875","volume":"176","author":"S van Beugen","year":"2017","unstructured":"van Beugen S, van Middendorp H, Ferwerda M,  et al. Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol. 2017;176(3):687\u201394.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1132_CR31","first-page":"195","volume":"100","author":"CB Taylor","year":"1985","unstructured":"Taylor CB, Sallis JF, Needle R. The relation of physical activity and exercise to mental health. Public Health Rep. 1985;100(2):195\u2013202.","journal-title":"Public Health Rep"},{"issue":"1","key":"1132_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12771","volume":"32","author":"SE Liang","year":"2019","unstructured":"Liang SE, Cohen JM, Ho RS. Psoriasis and suicidality: a review of the literature. Dermatol Ther. 2019;32(1): e12771.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1132_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2007.04.005","volume":"57","author":"SR Feldman","year":"2007","unstructured":"Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1132_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bjd.12372","volume":"169","author":"OD van Cranenburgh","year":"2013","unstructured":"van Cranenburgh OD, de Korte J, Sprangers MAG, de Rie MA, Smets EMA. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013;169(2):398\u2013405.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1132_CR35","first-page":"26","volume":"8","author":"T Finch","year":"2015","unstructured":"Finch T, Shim TN, Roberts L, Johnson O. Treatment satisfaction among patients with moderate-to-severe psoriasis. J Clin Aesthet Dermatol. 2015;8(4):26\u201330.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"1132_CR36","doi-asserted-by":"publisher","first-page":"2200570","DOI":"10.1080\/09546634.2023.2200570","volume":"34","author":"N Ninosu","year":"2023","unstructured":"Ninosu N, Hoelker S, Kappenstein M, Buettner S, Peitsch WK, Schaarschmidt M-L. Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness. J Dermatol Treat. 2023;34(1):2200570.","journal-title":"J Dermatol Treat"},{"issue":"6","key":"1132_CR37","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s12325-022-02124-2","volume":"39","author":"A Armstrong","year":"2022","unstructured":"Armstrong A, Edson-Heredia E, Zhu B, et al. Treatment goals for psoriasis as measured by patient benefit index: results of a National Psoriasis Foundation survey. Adv Ther. 2022;39(6):2657\u201367.","journal-title":"Adv Ther"},{"issue":"12","key":"1132_CR38","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1080\/14712598.2022.2113872","volume":"22","author":"E Camela","year":"2022","unstructured":"Camela E, Potestio L, Fabbrocini G, Ruggiero A, Megna M. New frontiers in personalized medicine in psoriasis. Expert Opin Biol Ther. 2022;22(12):1431\u20133.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"1132_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/13543784.2023.2219387","volume":"32","author":"E Camela","year":"2023","unstructured":"Camela E, Potestio L, Fabbrocini G, Pallotta S, Megna M. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opin Investig Drugs. 2023;32(6):537\u201352.","journal-title":"Expert Opin Investig Drugs"},{"issue":"4","key":"1132_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/jdv.14630","volume":"32","author":"Y Okubo","year":"2018","unstructured":"Okubo Y, Tsuruta D, Tang AC, et al. Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians. J Eur Acad Dermatol Venereol. 2018;32(4):606\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1132_CR41","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4.2.e13","volume":"4","author":"G Eysenbach","year":"2002","unstructured":"Eysenbach G, Wyatt J. Using the internet for surveys and health research. J Med Internet Res. 2002;4(2): e13.","journal-title":"J Med Internet Res"}],"updated-by":[{"DOI":"10.1007\/s13555-024-01168-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000}}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01132-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01132-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01132-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:03:39Z","timestamp":1718183019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01132-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01132-0","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13555-024-01168-2","URL":"https:\/\/doi.org\/10.1007\/s13555-024-01168-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Anthony Bewley has served as a consultant to Abbvie, Almirall, Celgene, Galderma, Janssen, Leo Pharma, Lilly, Novartis, Sanofi, and UCB; has participated in advisory boards for Psoriasis Association, Changing Faces, ISG, and NES; has received grants from EADV and travel grants from Janssen, Leo Pharma and Almirall; has participated in guidelines committees of BAD; is working as an editor for the book Practical Psychodermatology, as president for ESDaP and as a chair for APPGOS. Lauren Hiribane was an employee of Wefight during the study. Jordi Galv\u00e1n is an employee of Almirall. Sicily Mburu has no individual conflict of interest and is an employee of IFPA. The authors report no other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This research follows the European Pharmaceutical Market Research Association (EphMRA) code of conduct which outlines the European guidelines on market research and, as such, does not require Clinical Research Ethics Committee or Independent Review Board approval. According to the GDPR guidelines, respondents gave voluntary, informed consent to data collection and use, based on a clear explanation of the purpose of the data collection and the use(s) to which the data will be put.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}